Company · CIK 0000884731 · SIC 2836 — Biological Products, (No Diagnostic Substances)
ARIAD PHARMACEUTICALS INC · ARIA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2016 MForm 4 → | Feb 3, 4:43 pm EST | Timothy P ClacksonPresident, R&D, CSO | 29,333 | — | — | 364,719 | — | plan? |
| Feb 1, 2016 SForm 4 → | Feb 3, 4:41 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 14,667 | $4.81 | $70,548 | 141,463 | −9.39% | plan? |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:41 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 29,333 | — | — | 156,130 | — | plan? |
| Feb 1, 2016 SForm 4 → | Feb 3, 4:39 pm EST | Frank HaluskaSVP, Clinical R&D, CMO | 16,133 | $4.81 | $77,587 | 135,424 | −10.6% | plan? |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:39 pm EST | Frank HaluskaSVP, Clinical R&D, CMO | 29,333 | — | — | 151,557 | — | plan? |
| Feb 1, 2016 SForm 4 → | Feb 3, 4:38 pm EST | David L BersteinSVP, Chief IP Counsel | 14,667 | $4.81 | $70,515 | 250,115 | −5.54% | plan? |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:38 pm EST | David L BersteinSVP, Chief IP Counsel | 29,333 | — | — | 264,782 | — | plan? |
| Feb 1, 2016 SForm 4 → | Feb 3, 4:37 pm EST | Edward M FitzgeraldExecutive VP, CFO | 14,667 | $4.81 | $70,515 | 305,326 | −4.58% | plan? |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:37 pm EST | Edward M FitzgeraldExecutive VP, CFO | 29,333 | — | — | 319,993 | — | plan? |
| Feb 1, 2016 SForm 4 → | Feb 3, 4:35 pm EST | Maria E CantorSVP, Corporate Affairs | 16,133 | $4.82 | $77,745 | 123,117 | −11.6% | plan? |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:35 pm EST | Maria E CantorSVP, Corporate Affairs | 29,333 | — | — | 139,250 | — | plan? |
| Dec 31, 2015 FMForm 4 → | Jan 5, 2016, 5:41 pm EST | Harvey J M D BergerChairman & CEO, Director | 886,881 | $6.25 | $1,777,381 | 1,732,111 | — | plan? |
| Sep 28, 2015 SForm 4/A → | Sep 30, 4:14 pm EDT | David L BersteinSVP, Chief IP Counsel | 5,000 | $6.46 | $32,316 | 235,449 | −2.08% | plan? |
| Sep 28, 2015 SForm 4/A → | Sep 28, 6:35 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 5,000 | $6.46 | $32,316 | 126,797 | −3.79% | plan? |
| Sep 28, 2015 SForm 4 → | Sep 28, 6:14 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 5,000 | $6.46 | $32,316 | 126,797 | −3.79% | plan? |
| Sep 28, 2015 SForm 4 → | Sep 28, 6:09 pm EDT | Martin J DuvallEVP, CCO | 5,000 | $6.46 | $32,317 | 64,748 | −7.17% | plan? |
| Sep 28, 2015 SForm 4 → | Sep 28, 5:57 pm EDT | Maria E CantorSVP, Corporate Affairs | 5,000 | $6.47 | $32,327 | 109,917 | −4.35% | plan? |
| Sep 28, 2015 SForm 4 → | Sep 28, 5:50 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 8,750 | $6.46 | $56,551 | 289,231 | −2.94% | plan? |
| Sep 28, 2015 SForm 4 → | Sep 28, 5:40 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 5,500 | $6.46 | $35,503 | 122,224 | −4.31% | plan? |
| Sep 28, 2015 SForm 4 → | Sep 28, 5:36 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 8,750 | $6.46 | $56,560 | 334,086 | −2.55% | plan? |
| Sep 28, 2015 SForm 4 → | Sep 28, 5:02 pm EDT | David L BersteinSVP, Chief IP Counsel | 5,000 | $6.46 | $32,316 | 240,449 | −2.04% | plan? amended |
| Sep 24, 2015 MForm 4/A → | Sep 30, 4:14 pm EDT | David L BersteinSVP, Chief IP Counsel | 10,000 | — | — | 240,449 | — | plan? |
| Sep 24, 2015 MForm 4/A → | Sep 28, 6:35 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 10,000 | — | — | 131,797 | — | plan? |
| Sep 24, 2015 MForm 4 → | Sep 28, 6:14 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 10,000 | — | — | 131,797 | — | plan? |
| Sep 24, 2015 MForm 4 → | Sep 28, 6:09 pm EDT | Martin J DuvallEVP, CCO | 10,000 | — | — | 69,748 | — | plan? |
| Sep 24, 2015 MForm 4 → | Sep 28, 5:57 pm EDT | Maria E CantorSVP, Corporate Affairs | 10,000 | — | — | 114,917 | — | plan? |
| Sep 24, 2015 MForm 4 → | Sep 28, 5:50 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 17,500 | — | — | 297,981 | — | plan? |
| Sep 24, 2015 MForm 4 → | Sep 28, 5:40 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 10,000 | — | — | 127,724 | — | plan? |
| Sep 24, 2015 MForm 4 → | Sep 28, 5:36 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 17,500 | — | — | 342,836 | — | plan? |
| Sep 24, 2015 MForm 4 → | Sep 28, 5:02 pm EDT | David L BersteinSVP, Chief IP Counsel | 10,000 | — | — | 250,449 | — | plan? amended |
| Sep 24, 2015 MForm 4 → | Sep 28, 4:24 pm EDT | Harvey J M D BergerChairman & CEO, Director | 47,500 | — | — | 1,413,992 | — | plan? |
| Sep 1, 2015 SForm 4 → | Sep 3, 4:20 pm EDT | Maria E CantorSVP, Corporate Affairs | 2,696 | $9.11 | $24,557 | 104,917 | −2.51% | plan? |
| Aug 28, 2015 SForm 4 → | Sep 1, 5:14 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 32,858 | $10.00 | $328,580 | 280,481 | −10.5% | plan? |
| Aug 28, 2015 SForm 4 → | Sep 1, 5:14 pm EDT | Maria E CantorSVP, Corporate Affairs | 1,268 | $10.00 | $12,680 | 107,613 | −1.16% | plan? |
| Jul 16, 2015 SForm 4 → | Jul 16, 5:40 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 7,000 | $8.54 | $59,797 | 325,336 | −2.11% | plan? |
| Jul 16, 2015 SForm 4 → | Jul 16, 5:34 pm EDT | Martin J DuvallEVP, CCO | 1,400 | $8.54 | $11,956 | 59,748 | −2.29% | plan? |
| Jul 16, 2015 SForm 4 → | Jul 16, 5:25 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 7,000 | $8.54 | $59,793 | 313,339 | −2.19% | plan? |
| Jul 16, 2015 SForm 4 → | Jul 16, 5:14 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 4,000 | $8.54 | $34,164 | 121,797 | −3.18% | plan? |
| Jul 16, 2015 SForm 4 → | Jul 16, 5:12 pm EDT | Maria E CantorSVP, Corporate Affairs | 4,000 | $8.54 | $34,162 | 108,881 | −3.54% | plan? |
| Jul 16, 2015 SForm 4 → | Jul 16, 5:10 pm EDT | David L BersteinSVP, Chief IP Counsel | 4,000 | $8.54 | $34,162 | 230,449 | −1.71% | plan? |
| Jul 16, 2015 SForm 4 → | Jul 16, 5:08 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 4,400 | $8.54 | $37,575 | 117,724 | −3.60% | plan? |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:40 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 14,000 | — | — | 332,336 | — | plan? |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:34 pm EDT | Martin J DuvallEVP, CCO | 2,800 | — | — | 61,148 | — | plan? |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:25 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 14,000 | — | — | 320,339 | — | plan? |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:14 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 8,000 | — | — | 125,797 | — | plan? |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:12 pm EDT | Maria E CantorSVP, Corporate Affairs | 8,000 | — | — | 112,881 | — | plan? |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:10 pm EDT | David L BersteinSVP, Chief IP Counsel | 8,000 | — | — | 234,449 | — | plan? |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:08 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 8,000 | — | — | 122,124 | — | plan? |
| Jul 15, 2015 FMForm 4 → | Jul 16, 4:22 pm EDT | Harvey J M D BergerChairman & CEO, Director | 54,170 | $8.35 | $145,040 | 1,366,492 | — | plan? |
| Jun 25, 2015 FMForm 4 → | Feb 7, 2017, 4:59 pm EST | Hugh M ColeSVP, Chief Business Officer | 25,416 | $8.69 | $54,304 | 42,834 | — | plan? late |
| May 1, 2015 SForm 4 → | May 4, 4:36 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 60,000 | $8.80 | $528,000 | 305,852 | −16.4% | plan? |
| May 1, 2015 MForm 4 → | May 4, 4:36 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 60,000 | $7.56 | $453,600 | 365,852 | — | plan? |
| Apr 23, 2015 SForm 4 → | Apr 27, 4:14 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 123,766 | $9.50 | $1,175,777 | 316,548 | −28.1% | plan? |
| Mar 26, 2015 FMForm 4 → | Mar 30, 4:21 pm EDT | Harvey J M D BergerChairman & CEO, Director | 277,194 | $7.84 | $2,173,175 | 1,343,460 | — | plan? |
| Mar 20, 2015 SForm 4/A → | Mar 23, 6:26 pm EDT | David L BersteinSVP, Chief IP Counsel | 4,375 | $8.72 | $38,144 | 226,449 | −1.90% | plan? |
| Mar 20, 2015 SForm 4 → | Mar 23, 6:06 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 7,000 | $8.72 | $61,051 | 117,797 | −5.61% | plan? |
| Mar 20, 2015 SForm 4 → | Mar 23, 6:02 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 9,584 | $8.72 | $83,539 | 305,209 | −3.04% | plan? |
| Mar 20, 2015 SForm 4 → | Mar 23, 5:59 pm EDT | Martin J DuvallEVP, CCO | 4,834 | $8.80 | $42,526 | 54,950 | −8.09% | plan? |
| Mar 20, 2015 SForm 4 → | Mar 23, 5:54 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 6,875 | $8.71 | $59,863 | 114,124 | −5.68% | plan? |
| Mar 20, 2015 SForm 4 → | Mar 23, 5:27 pm EDT | David L BersteinSVP, Chief IP Counsel | 4,375 | $8.72 | $38,144 | 159,907 | −2.66% | plan? |
| Mar 19, 2015 MForm 4/A → | Mar 23, 6:26 pm EDT | David L BersteinSVP, Chief IP Counsel | 8,750 | — | — | 228,449 | — | plan? |
| Mar 19, 2015 SForm 4 → | Mar 23, 6:16 pm EDT | Maria E CantorSVP, Corporate Affairs and HR | 16,954 | $8.86 | $150,232 | 104,881 | −13.9% | plan? |
| Mar 19, 2015 MForm 4 → | Mar 23, 6:16 pm EDT | Maria E CantorSVP, Corporate Affairs and HR | 21,708 | $3.08 | $24,255 | 108,916 | — | plan? |
| Mar 19, 2015 MForm 4 → | Mar 23, 6:06 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 14,000 | — | — | 120,797 | — | plan? |
| Mar 19, 2015 MForm 4 → | Mar 23, 6:03 pm EDT | Harvey J M D BergerChairman & CEO, Director | 70,000 | — | — | 1,320,654 | — | plan? |
| Mar 19, 2015 MForm 4 → | Mar 23, 6:02 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 19,166 | — | — | 309,376 | — | plan? |
| Mar 19, 2015 MForm 4 → | Mar 23, 5:59 pm EDT | Martin J DuvallEVP, CCO | 9,667 | — | — | 55,784 | — | plan? |
| Mar 19, 2015 MForm 4 → | Mar 23, 5:54 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 12,500 | — | — | 117,424 | — | plan? |
| Mar 19, 2015 SForm 4 → | Mar 23, 5:45 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 32,741 | $8.88 | $290,839 | 440,314 | −6.92% | plan? |
| Mar 19, 2015 MForm 4 → | Mar 23, 5:45 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 44,823 | $7.56 | $156,167 | 446,981 | — | plan? |
| Mar 19, 2015 MForm 4 → | Mar 23, 5:27 pm EDT | David L BersteinSVP, Chief IP Counsel | 8,750 | — | — | 228,449 | — | plan? |
| Mar 16, 2015 SForm 4 → | Mar 18, 4:23 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 34,425 | $8.62 | $296,651 | 110,797 | −23.7% | plan? |
| Mar 16, 2015 MForm 4 → | Mar 18, 4:23 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 7,500 | $1.30 | $9,750 | 145,222 | — | plan? |
| Feb 20, 2015 SForm 4 → | Feb 24, 4:23 pm EST | Timothy P ClacksonPresident, R&D, CSO | 49,035 | $8.00 | $392,280 | 428,232 | −10.3% | plan? |
| Feb 20, 2015 MForm 4 → | Feb 24, 4:23 pm EST | Timothy P ClacksonPresident, R&D, CSO | 49,035 | $3.54 | $173,419 | 452,268 | — | plan? |
| Feb 11, 2015 PForm 4 → | Feb 13, 4:21 pm EST | Harvey J M D BergerChairman & CEO, Director | 25,000 | $6.83 | $170,849 | 1,864,286 | +1.36% | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 4:52 pm EST | Frank HaluskaSVP, Clinical R&D, CMO | 16,134 | $6.33 | $102,107 | 108,499 | −12.9% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:52 pm EST | Frank HaluskaSVP, Clinical R&D, CMO | 29,334 | — | — | 124,633 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 4:19 pm EST | Maria E CantorSVP, Corporate Affairs and HR | 16,134 | $6.33 | $102,089 | 100,129 | −13.9% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:19 pm EST | Maria E CantorSVP, Corporate Affairs and HR | 29,334 | — | — | 116,263 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 4:18 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 14,667 | $6.33 | $92,823 | 137,722 | −9.62% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:18 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 29,334 | — | — | 152,389 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 4:17 pm EST | Timothy P ClacksonPresident, R&D, CSO | 14,667 | $6.33 | $92,820 | 428,232 | −3.31% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:17 pm EST | Timothy P ClacksonPresident, R&D, CSO | 29,334 | — | — | 442,899 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 4:16 pm EST | Martin J DuvallEVP, CCO | 14,667 | $6.33 | $92,823 | 50,117 | −22.6% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:16 pm EST | Martin J DuvallEVP, CCO | 29,334 | — | — | 64,784 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 4:16 pm EST | Edward M FitzgeraldExecutive VP, CFO | 14,667 | $6.33 | $92,849 | 295,627 | −4.73% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:16 pm EST | Edward M FitzgeraldExecutive VP, CFO | 29,334 | — | — | 310,294 | — | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:15 pm EST | Harvey J M D BergerChairman & CEO, Director | 87,000 | — | — | 1,250,564 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 4:14 pm EST | David L BersteinSVP, Chief IP Counsel | 14,667 | $6.33 | $92,826 | 222,074 | −6.20% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:14 pm EST | David L BersteinSVP, Chief IP Counsel | 29,334 | — | — | 236,741 | — | plan? |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:38 pm EST | Alexander J DennerDirector | 22,665 | — | — | 22,665 | — | plan? late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:37 pm EST | Wayne WilsonDirector | 12,500 | — | — | 113,000 | — | plan? late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:37 pm EST | Sarah J. SchlesingerDirector | 12,500 | — | — | 25,000 | — | plan? late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:36 pm EST | Norbert G RiedelDirector | 12,500 | — | — | 109,359 | — | plan? late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:35 pm EST | Massimo RadaelliDirector | 12,500 | — | — | 93,000 | — | plan? late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:34 pm EST | Athanese LavidasDirector | 12,500 | — | — | 119,131 | — | plan? late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:34 pm EST | Jay R LamarcheDirector | 12,500 | — | — | 439,705 | — | plan? late |
| Jan 22, 2015 PForm 4 → | Jan 26, 4:09 pm EST | Harvey J M D BergerChairman & CEO, Director | 25,000 | $6.17 | $154,240 | 1,839,286 | +1.38% | plan? |
| Jan 13, 2015 PForm 4 → | Jan 15, 4:30 pm EST | Sarah J. SchlesingerDirector | 2,600 | $6.61 | $17,186 | 15,600 | +20.0% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2015 AMForm 4 → | Sep 28, 5:40 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 30,000 | — | — | 20,000 | — | |
| Sep 24, 2015 AMForm 4 → | Sep 28, 5:36 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 52,500 | — | — | 35,000 | — | |
| Sep 24, 2015 AMForm 4 → | Sep 28, 5:02 pm EDT | David L BersteinSVP, Chief IP Counsel | 30,000 | — | — | 20,000 | — | amended |
| Sep 24, 2015 AMForm 4 → | Sep 28, 4:24 pm EDT | Harvey J M D BergerChairman & CEO, Director | 142,500 | — | — | 47,500 | — | |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:40 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 14,000 | — | — | 0 | — | |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:34 pm EDT | Martin J DuvallEVP, CCO | 2,800 | — | — | 0 | — | |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:25 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 14,000 | — | — | 0 | — | |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:14 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 8,000 | — | — | 0 | — | |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:12 pm EDT | Maria E CantorSVP, Corporate Affairs | 8,000 | — | — | 0 | — | |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:10 pm EDT | David L BersteinSVP, Chief IP Counsel | 8,000 | — | — | 0 | — | |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:08 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 8,000 | — | — | 0 | — | |
| Jul 15, 2015 MForm 4 → | Jul 16, 4:22 pm EDT | Harvey J M D BergerChairman & CEO, Director | 36,800 | — | — | 0 | — | |
| Jun 25, 2015 AMForm 4 → | Feb 7, 2017, 4:59 pm EST | Hugh M ColeSVP, Chief Business Officer | 28,955 | — | — | 9,788 | — | late |
| May 1, 2015 MForm 4 → | May 4, 4:36 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 60,000 | — | — | 0 | — | |
| Apr 30, 2015 AForm 4 → | Apr 30, 4:22 pm EDT | Maria E CantorSVP, Corporate Affairs | 40,000 | — | — | 40,000 | — | |
| Apr 29, 2015 AForm 4 → | Apr 30, 4:35 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 52,000 | — | — | 52,000 | — | |
| Apr 29, 2015 AForm 4 → | Apr 30, 4:31 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 52,000 | — | — | 52,000 | — | |
| Apr 29, 2015 AForm 4 → | Apr 30, 4:30 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 54,000 | — | — | 54,000 | — | |
| Apr 29, 2015 AForm 4 → | Apr 30, 4:28 pm EDT | David L BersteinSVP, Chief IP Counsel | 40,000 | — | — | 40,000 | — | |
| Apr 29, 2015 AForm 4 → | Apr 30, 4:26 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 70,200 | — | — | 70,200 | — | |
| Apr 29, 2015 AForm 4 → | Apr 30, 4:25 pm EDT | Hugh M ColeSVP, Chief Business Officer | 52,000 | — | — | 52,000 | — | |
| Apr 29, 2015 AForm 4 → | Apr 30, 4:24 pm EDT | Martin J DuvallEVP, CCO | 54,000 | — | — | 54,000 | — | |
| Apr 28, 2015 AForm 4 → | Apr 30, 4:36 pm EDT | Harvey J M D BergerChairman & CEO, Director | 345,000 | — | — | 345,000 | — | |
| Apr 28, 2015 AForm 4 → | Apr 30, 4:34 pm EDT | Anna ProtopapasDirector | 75,000 | — | — | 75,000 | — | |
| Mar 26, 2015 MForm 4 → | Mar 30, 4:21 pm EDT | Harvey J M D BergerChairman & CEO, Director | 150,000 | — | — | 0 | — | |
| Mar 19, 2015 MForm 4/A → | Mar 23, 6:26 pm EDT | David L BersteinSVP, Chief IP Counsel | 8,750 | — | — | 0 | — | |
| Mar 19, 2015 MForm 4 → | Mar 23, 6:16 pm EDT | Maria E CantorSVP, Corporate Affairs and HR | 21,708 | — | — | 0 | — | |
| Mar 19, 2015 MForm 4 → | Mar 23, 6:06 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 14,000 | — | — | 0 | — | |
| Mar 19, 2015 MForm 4 → | Mar 23, 6:03 pm EDT | Harvey J M D BergerChairman & CEO, Director | 70,000 | — | — | 0 | — | |
| Mar 19, 2015 MForm 4 → | Mar 23, 6:02 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 19,166 | — | — | 0 | — | |
| Mar 19, 2015 MForm 4 → | Mar 23, 5:59 pm EDT | Martin J DuvallEVP, CCO | 9,667 | — | — | 0 | — | |
| Mar 19, 2015 MForm 4 → | Mar 23, 5:54 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 12,500 | — | — | 0 | — | |
| Mar 19, 2015 MForm 4 → | Mar 23, 5:45 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 44,823 | — | — | 0 | — | |
| Mar 19, 2015 MForm 4 → | Mar 23, 5:27 pm EDT | David L BersteinSVP, Chief IP Counsel | 8,750 | — | — | 0 | — | |
| Mar 16, 2015 MForm 4 → | Mar 18, 4:23 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 7,500 | — | — | 3,750 | — | |
| Feb 20, 2015 MForm 4 → | Feb 24, 4:23 pm EST | Timothy P ClacksonPresident, R&D, CSO | 49,035 | — | — | 31,422 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 4:25 pm EST | Thomas DesRosierEVP, General Counsel | 240,000 | — | — | 130,000 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:52 pm EST | Frank HaluskaSVP, Clinical R&D, CMO | 29,334 | — | — | 58,666 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:19 pm EST | Maria E CantorSVP, Corporate Affairs and HR | 29,334 | — | — | 58,666 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:18 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 29,334 | — | — | 58,666 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:17 pm EST | Timothy P ClacksonPresident, R&D, CSO | 29,334 | — | — | 58,666 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:16 pm EST | Martin J DuvallEVP, CCO | 29,334 | — | — | 58,666 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:16 pm EST | Edward M FitzgeraldExecutive VP, CFO | 29,334 | — | — | 58,666 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:15 pm EST | Harvey J M D BergerChairman & CEO, Director | 87,000 | — | — | 174,000 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 4:14 pm EST | David L BersteinSVP, Chief IP Counsel | 29,334 | — | — | 58,666 | — | |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:38 pm EST | Alexander J DennerDirector | 25,000 | $6.45 | $161,250 | 25,000 | — | late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:37 pm EST | Wayne WilsonDirector | 25,000 | $6.45 | $161,250 | 25,000 | — | late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:37 pm EST | Sarah J. SchlesingerDirector | 25,000 | $6.45 | $161,250 | 12,500 | — | late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:36 pm EST | Norbert G RiedelDirector | 25,000 | $6.45 | $161,250 | 25,000 | — | late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:35 pm EST | Massimo RadaelliDirector | 25,000 | $6.45 | $161,250 | 25,000 | — | late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:34 pm EST | Athanese LavidasDirector | 25,000 | $6.45 | $161,250 | 25,000 | — | late |
| Jan 31, 2015 AForm 4 → | Feb 4, 4:34 pm EST | Jay R LamarcheDirector | 25,000 | $6.45 | $161,250 | 25,000 | — | late |